BioScience Health Innovations (BHIC) FCF Margin (2023 - 2025)
Historic FCF Margin for BioScience Health Innovations (BHIC) over the last 3 years, with Q3 2025 value amounting to 30.09%.
- BioScience Health Innovations' FCF Margin fell 392100.0% to 30.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.71%, marking a year-over-year increase of 36000.0%. This contributed to the annual value of 1.26% for FY2024, which is 527700.0% up from last year.
- Latest data reveals that BioScience Health Innovations reported FCF Margin of 30.09% as of Q3 2025, which was down 392100.0% from 16.22% recorded in Q2 2025.
- Over the past 5 years, BioScience Health Innovations' FCF Margin peaked at 26.76% during Q1 2025, and registered a low of 206.18% during Q1 2023.
- Its 3-year average for FCF Margin is 37.41%, with a median of 17.31% in 2024.
- In the last 5 years, BioScience Health Innovations' FCF Margin skyrocketed by 1888800bps in 2024 and then crashed by -392100bps in 2025.
- Quarter analysis of 3 years shows BioScience Health Innovations' FCF Margin stood at 18.59% in 2023, then soared by 56bps to 8.24% in 2024, then plummeted by -265bps to 30.09% in 2025.
- Its FCF Margin was 30.09% in Q3 2025, compared to 16.22% in Q2 2025 and 26.76% in Q1 2025.